title: [Prognosis of the hemorrhage recurrence in the patients suffering from acute gastroduodenal ulcer bleeding].
abstract: The prognostication method for the hemorrhage recurrence, permitting to estimate the risk of its occurrence and to prescribe an adequate antirecurrence treatment, was proposed. Among numerous predictors of recurrence the most significant clinical, endoscopic and laboratory factors were selected to raise the prognostication precision. Depending on therisk degree of a recurrent hemorrhage, different methods of treatment were prescribed to the patients. The proposed method was applied in 112 patients, suffering ulcer gastroduodenal hemorrhage. The hemorrhage recurrence have had occurred in 45 (43.3%) of them, in 5 (4.46%)--operative intervention was conducted, using organpreserving methods. General lethality have had constituted 0.89%, postoperative one in a control group--7.14%, and in the main all the patients were alive. The method proposed permits with a high precision to prognosticate and to determine effective tactics of treatment. Taking into account the additional factors of risk raises the prognosis precision and permits to prescribe antihelicobacter therapy and the proton pump inhibirors in a rational dosage soundly.
authors.forename: E A
authors.initials: EA
authors.lastname: Iaroshenko
authors.forename: V I
authors.initials: VI
authors.lastname: Didenko
authors.forename: V I
authors.initials: VI
authors.lastname: Tsipko
authors.forename: V N
authors.initials: VN
authors.lastname: Grabchuk
authors.forename: E I
authors.initials: EI
authors.lastname: Cherednichenko
authors.forename: A M
authors.initials: AM
authors.lastname: Bendetskiĭ
authors.forename: N N
authors.initials: NN
authors.lastname: Pisareva
authors.forename: N G
authors.initials: NG
authors.lastname: Gasparian
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy / Q000601:surgery*; D010438:Peptic Ulcer Hemorrhage / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery*; D011379:Prognosis; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D012107:Research Design; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors